Category: Healthcare

  • Gene Editing Tools Market

    —

    by

    The gene editing tools market was valued at USD 6.2 billion in 2026 and is projected to reach USD 15.8 billion by 2033, expanding at a CAGR of 14.2% during the forecast period.

  • Gene Therapy in CNS Disorder Market

    —

    by

    The gene therapy in CNS disorder market was valued at USD 2.1 billion in 2026 and is projected to reach USD 8.7 billion by 2033, reflecting a robust CAGR of 22.4% during the forecast period.

  • Gene Prediction Tools Market

    —

    by

    The gene prediction tools market size is projected to reach USD 1.48 billion by 2033, up from USD 0.82 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.7% during the forecast period.

  • 3D-Imaging Surgical Solution Market

    —

    by

    The global 3D-Imaging Surgical Solution market size is projected to reach USD 5.8 billion by 2033, up from USD 2.7 billion in 2026, reflecting a robust CAGR of 11.2% during the forecast period.

  • Next Generation Biomanufacturing Market

    —

    by

    The next generation biomanufacturing market is projected to grow from a base value of USD 12.8 billion in 2026 to USD 32.7 billion by 2033, reflecting a robust CAGR of 14.2% over the forecast period.

  • Next Generation Immunotherapies Market

    —

    by

    The next generation immunotherapies market size is projected to reach USD 52.8 billion by 2033, up from USD 18.7 billion in 2026, reflecting a compound annual growth rate (CAGR) of 16.2% during the forecast period.

  • Next Generation Mass Spectrometer Market

    —

    by

    The next generation mass spectrometer market is projected to grow from a base value of USD 3.2 billion in 2026 to USD 6.7 billion by 2033, registering a robust CAGR of 11.1% during the forecast period.

  • Next Generation Molecular Assay Market

    —

    by

    The next generation molecular assay market size is projected to grow from USD 4.2 billion in 2026 to USD 10.8 billion by 2033, at a CAGR of 14.2% during the forecast period.

  • Blood Cancer Treatment Market

    —

    by

    In 2026, the blood cancer treatment market is estimated to be valued at USD 45.2 billion, with projections indicating a rise to USD 81.7 billion by 2033, reflecting a robust CAGR of 8.7%.

  • Biosensors Market

    —

    by

    In 2026, the biosensors market is estimated to be valued at USD 29.4 billion, with projections indicating a rise to USD 54.7 billion by 2033, reflecting a CAGR of 9.3% during the forecast period.